(-)-Thalidomide arene oxide (CHEM122216)
| Record Information | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Version | 1.0 | ||||||||
| Creation Date | 2026-04-06 09:54:41 UTC | ||||||||
| Update Date | 2026-08-27 22:51:31 UTC | ||||||||
| Accession Number | CHEM122216 | ||||||||
| Identification | |||||||||
| Common Name | (-)-Thalidomide arene oxide | ||||||||
| Class | Small Molecule | ||||||||
| Description | (-)-Thalidomide arene oxide is an organic compound with the formula C13H10N2O5 and an average molecular weight of 274.23 g/mol. (-)-Thalidomide arene oxide belongs to the isoindolines, a subclass of isoindoles and derivatives within the organic compounds. This substance has been identified in or released from 13 recorded sources across multiple sectors. Within the healthcare, pharmaceuticals & veterinary products sector, it is associated with medical devices. In the energy, oil & gas and industrial manufacturing & chemical processing sectors, it is found in lubricants. Its presence is also recorded in food packaging within the food, food processing & cookware sector, as well as in synthetic textiles and carpets and rugs within the textiles, leather & furnishings sector. Additionally, it is linked to electrical & electronic equipment, including batteries, printed circuit boards, capacitors, wires and cables, and cell phones, along with one other sector. Recorded routes of exposure for this compound include oral, inhalation, and touch. | ||||||||
| Contaminant Sources | Not Available | ||||||||
| Contaminant Type |
| ||||||||
| Chemical Structure |  | ||||||||
| Synonyms | Not Available | ||||||||
| Chemical Formula | C13H10N2O5 | ||||||||
| Average Molecular Mass | Not Available | ||||||||
| Monoisotopic Mass | 274.059 g/mol | ||||||||
| CAS Registry Number | Not Available | ||||||||
| IUPAC Name | 4-[(3S)-2,6-dioxopiperidin-3-yl]-1a,6a-dihydrooxireno[2,3-f]isoindole-3,5-dione | ||||||||
| Traditional Name | Not Available | ||||||||
| SMILES | C1CC(=O)NC(=O)[C@H]1N2C(=O)C3=CC4C(O4)C=C3C2=O | ||||||||
| InChI Identifier | InChI=1S/C13H10N2O5/c16-10-2-1-7(11(17)14-10)15-12(18)5-3-8-9(20-8)4-6(5)13(15)19/h3-4,7-9H,1-2H2,(H,14,16,17)/t7-,8?,9?/m0/s1 | ||||||||
| InChI Key | MLUCRLHVMELD-UEJVZZJDSA-N | ||||||||
| Chemical Taxonomy | |||||||||
| Classification | Not classified | ||||||||
| Biological Properties | |||||||||
| Status | Detected and Not Quantified | ||||||||
| Origin | Not Available | ||||||||
| Cellular Locations | Not Available | ||||||||
| Biofluid Locations | Not Available | ||||||||
| Tissue Locations | Not Available | ||||||||
| Pathways | Not Available | ||||||||
| Applications | Not Available | ||||||||
| Biological Roles | Not Available | ||||||||
| Chemical Roles | Not Available | ||||||||
| Physical Properties | |||||||||
| State | Not Available | ||||||||
| Appearance | Not Available | ||||||||
| Experimental Properties |
| ||||||||
| Predicted Properties | Not Available | ||||||||
| Spectra | |||||||||
| Spectra |
| ||||||||
| Toxicity Profile | |||||||||
| Route of Exposure | Not Available | ||||||||
| Mechanism of Toxicity | Not Available | ||||||||
| Metabolism | Not Available | ||||||||
| Toxicity Values | Not Available | ||||||||
| Lethal Dose | Not Available | ||||||||
| Carcinogenicity (IARC Classification) | Not Available | ||||||||
| Uses/Sources | Not Available | ||||||||
| Minimum Risk Level | Not Available | ||||||||
| Health Effects | Not Available | ||||||||
| Symptoms | Not Available | ||||||||
| Treatment | Not Available | ||||||||
| Concentrations | |||||||||
| Not Available | |||||||||
| External Links | |||||||||
| Identifiers | Not Available | ||||||||
| References | |||||||||
| Synthesis Reference | Not Available | ||||||||
| MSDS | Not Available | ||||||||
| General References | Not Available | ||||||||
